Neuropsychiatric Manifestations of Human Leukocyte Interferon Therapy in Patients With Cancer

JAMA: The Journal of the American Medical Association

Volumn 252, Issue 7, 1984, Pages 938-941

  Adams, Frank ^a   Quesada, Jorge R ^a   Gutterman, Jordan U ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

ADVERSE DRUG REACTION; AFFECTION; ASTHENIA; CANCER CHEMOTHERAPY; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; COGNITION; DRUG THERAPY; FATIGUE; HUMAN; INTOXICATION; INTRAMUSCULAR DRUG ADMINISTRATION; KIDNEY; KIDNEY CANCER; KIDNEY CARCINOMA; MUSCLE; NERVOUS SYSTEM; NEURASTHENIA; NEUROTOXICITY; PERSONALITY; PSYCHOLOGICAL ASPECT; THERAPY;

ADENOCARCINOMA; ADULT; AFFECT; AGED; ASTHENIA; BEHAVIOR; COGNITION; FATIGUE; FEMALE; HUMAN; INTERFERON TYPE I; KIDNEY NEOPLASMS; MALE; MIDDLE AGE; PSYCHOMOTOR PERFORMANCE; SUPPORT, NON-U.S. GOV'T;

EID: 0021172947     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1984.03350070056026     Document Type: Article

References (21)

1. Gutterman J, Blumenschein JR, Alexanian R, et al.: Leukocyte interferon induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma. Ann Intern Med 1980;83:399-406.
2. Quesada JR, Swanson D, Trindade A, et al.: Antitumor effects of partially pure human leukocyte interferon in renal cell carcinoma. Cancer Res 1982;43:940-947.
3. Scott GM, Secher DS, Flowers D: Toxicity of interferon. Br Med J 1981;282:1345.
4. Cantell K, Hirvonen S: Large-scale production of human leukocyte interferon containing 10 units per ml. J Gen Virol 1978;39:541-543.
5. Hutt ML: The Hutt Adaptation of the Bender-Gestalt Test, ed 2. New York, Grune & Stratton Inc, 1969.
6. Reitan R: Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1978;8:271-276.
7. Wechsler D: Wechsler Adult Intelligence Scale Manual. New York, Psychological Corp, 1955.
8. Lishman AL: Organic Psychiatry: The Psychological Consequences of Cerebral Disorder. Oxford, England, Blackwell Scientific Publications, 1978, pp 109-175.
9. Strub RL, Black WF: Organic Brain Syndromes: An Introduction to Neurobehavioral Disorders. Philadelphia, FA Davis Co, 1981, pp 38-85.
10. Smedley H, Katrak M, Sikora K, et al.: Neurological effects of recombinant human interferon. Br Med J 1983;286:262-264.
11. Rohatiner AZS, Prior PF, Burton AC, et al.: Central nervous systemic toxicity of interferon. Br J Cancer 1983;47:418-422.
12. Cantell K, Mattson K, Nirranan A, et al.: Neurotoxicity of IFN. Read before the Third International Congress of Interferon Research, Miami, Nov 1-3, 1982.
13. Damasio A: The frontal lobes, in Heilman KM, Valenstein E (eds): Clinical Neuropsychology. New York, Oxford University Press, 1979, pp 360-412.
14. Hecaen H, Albert ML: Disorders of mental functioning related to frontal lobe pathology, in Benson FS, Blumer D (eds): Psychiatric Aspects of Neurological Disease: Seminars in Psychiatry. New York, Grune & Stratton Inc, 1974, pp 137-149.
15. Luria AR: Frontal lobe syndromes, in Vinken PJ, Bruyn GW (eds): Handbook of Clinical Neurology. New York, Elsevier North Holland Inc, 1969, vol 2, pp 725-757.
16. Fuster JM: The Prefrontal Cortex: Anatomy, Physiology and Neuropsychology of the Frontal Lobe. New York, Raven Press, 1978, pp111-124.
17. Luria AR: Higher Cortical Functions in Man, ed 2. New York, Basic Books Inc, 1980, pp 246-359.
18. Gutterman JU, Fine S, Quesada J, et al.: Recombinant leukocyte A interferon: Pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients. Ann Intern Med 1982;96:549-556.
19. Calvet MC, Gresser I: Interferon enhances the excitability of cultures neurons. Nature 1979;178:558-560.
20. Maheshware RK, Lazo PS, Friedman RM: Enhancement of interferon activity by a membrane glycoprotein related to the thyrotropin receptor, in Khan S, Hill NO, Dorn GL (eds): Interferon: Properties and Clinical Uses. Dallas, Leland Fikes Foundation Press of the Wadley Institute of Molecular Medicine, 1979, pp 387-396.
21. Blalock JE, Smith EM: Human leukocyte interferon: Potent endorphin-like opioid activity. Biochem Biophys Res Commun 1981;101:472-478.